Limited Use Note(s)

Government of Ontario Logo
ROTIGOTINE2mg/24hr Trans Patch
Reason For Use CodeClinical Criteria
510For adjunctive therapy to levodopa for the treatment of patients with advanced stage Parkinson's disease (APD).
LU Authorization Period: Indefinite